Your browser doesn't support javascript.
Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.
Ramaswamy, Anjali; Brodsky, Nina N; Sumida, Tomokazu S; Comi, Michela; Asashima, Hiromitsu; Hoehn, Kenneth B; Li, Ningshan; Liu, Yunqing; Shah, Aagam; Ravindra, Neal G; Bishai, Jason; Khan, Alamzeb; Lau, William; Sellers, Brian; Bansal, Neha; Guerrerio, Pamela; Unterman, Avraham; Habet, Victoria; Rice, Andrew J; Catanzaro, Jason; Chandnani, Harsha; Lopez, Merrick; Kaminski, Naftali; Dela Cruz, Charles S; Tsang, John S; Wang, Zuoheng; Yan, Xiting; Kleinstein, Steven H; van Dijk, David; Pierce, Richard W; Hafler, David A; Lucas, Carrie L.
  • Ramaswamy A; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA.
  • Brodsky NN; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA; Department of Pediatrics, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Sumida TS; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA; Department of Neurology, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Comi M; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA; Department of Neurology, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Asashima H; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA; Department of Neurology, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Hoehn KB; Department of Pathology, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Li N; Department of Biostatistics, Yale School of Public Health, New Haven, CT, 06520, USA.
  • Liu Y; Department of Biostatistics, Yale School of Public Health, New Haven, CT, 06520, USA.
  • Shah A; Department of Internal Medicine (Cardiology), Yale University School of Medicine, New Haven, CT, 06510, USA; Department of Computer Science, Yale University, New Haven, CT, 06520, USA.
  • Ravindra NG; Department of Internal Medicine (Cardiology), Yale University School of Medicine, New Haven, CT, 06510, USA; Department of Computer Science, Yale University, New Haven, CT, 06520, USA.
  • Bishai J; Department of Internal Medicine (Cardiology), Yale University School of Medicine, New Haven, CT, 06510, USA; Department of Computer Science, Yale University, New Haven, CT, 06520, USA.
  • Khan A; Department of Pediatrics, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Lau W; NIH Center for Human Immunology (CHI), NIAID, NIH, Bethesda, MD, 20892, USA; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, 20892, USA.
  • Sellers B; NIH Center for Human Immunology (CHI), NIAID, NIH, Bethesda, MD, 20892, USA.
  • Bansal N; NIH Center for Human Immunology (CHI), NIAID, NIH, Bethesda, MD, 20892, USA; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, 20892, USA.
  • Guerrerio P; Food Allergy Research Section, Laboratory of Allergic Diseases, NIAID, NIH, Bethesda, MD, 20892, USA.
  • Unterman A; Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New, Haven, CT, 06520, USA.
  • Habet V; Department of Pediatrics, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Rice AJ; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA.
  • Catanzaro J; Department of Pediatrics, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Chandnani H; Department of Pediatrics, Loma Linda School of Medicine, Loma Linda, CA, 92354, USA.
  • Lopez M; Department of Pediatrics, Loma Linda School of Medicine, Loma Linda, CA, 92354, USA.
  • Kaminski N; Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New, Haven, CT, 06520, USA.
  • Dela Cruz CS; Section of Pulmonary, Critical Care and Sleep Medicine, Yale University School of Medicine, New, Haven, CT, 06520, USA.
  • Tsang JS; NIH Center for Human Immunology (CHI), NIAID, NIH, Bethesda, MD, 20892, USA; Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD, 20892, USA.
  • Wang Z; Department of Biostatistics, Yale School of Public Health, New Haven, CT, 06520, USA.
  • Yan X; Department of Biostatistics, Yale School of Public Health, New Haven, CT, 06520, USA; Department of Computer Science, Yale University, New Haven, CT, 06520, USA.
  • Kleinstein SH; Department of Pathology, Yale University School of Medicine, New Haven, CT, 06520, USA; Interdepartmental Program in Computational Biology and Bioinformatics, Yale University, New Haven, CT, 06511, USA.
  • van Dijk D; Department of Internal Medicine (Cardiology), Yale University School of Medicine, New Haven, CT, 06510, USA; Department of Computer Science, Yale University, New Haven, CT, 06520, USA.
  • Pierce RW; Department of Pediatrics, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Hafler DA; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA; Department of Neurology, Yale University School of Medicine, New Haven, CT, 06520, USA.
  • Lucas CL; Department of Immunobiology, Yale University School of Medicine, New Haven, CT, 06519, USA. Electronic address: carrie.lucas@yale.edu.
Immunity ; 54(5): 1083-1095.e7, 2021 05 11.
Article in English | MEDLINE | ID: covidwho-1179682
ABSTRACT
Multisystem inflammatory syndrome in children (MIS-C) is a life-threatening post-infectious complication occurring unpredictably weeks after mild or asymptomatic SARS-CoV-2 infection. We profiled MIS-C, adult COVID-19, and healthy pediatric and adult individuals using single-cell RNA sequencing, flow cytometry, antigen receptor repertoire analysis, and unbiased serum proteomics, which collectively identified a signature in MIS-C patients that correlated with disease severity. Despite having no evidence of active infection, MIS-C patients had elevated S100A-family alarmins and decreased antigen presentation signatures, indicative of myeloid dysfunction. MIS-C patients showed elevated expression of cytotoxicity genes in NK and CD8+ T cells and expansion of specific IgG-expressing plasmablasts. Clinically severe MIS-C patients displayed skewed memorycell TCR repertoires and autoimmunity characterized by endothelium-reactive IgG. The alarmin, cytotoxicity, TCR repertoire, and plasmablast signatures we defined have potential for application in the clinic to better diagnose and potentially predict disease severity early in the course of MIS-C.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Adolescent / Child / Child, preschool / Humans Language: English Journal: Immunity Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.immuni.2021.04.003

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Systemic Inflammatory Response Syndrome / SARS-CoV-2 / COVID-19 Type of study: Prognostic study Limits: Adolescent / Child / Child, preschool / Humans Language: English Journal: Immunity Journal subject: Allergy and Immunology Year: 2021 Document Type: Article Affiliation country: J.immuni.2021.04.003